PATENT CLAIM ANALYSIS

Application Number: 16156867
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-01
Patent Classification: ["530", "351000"]

Abstract:
The present invention refers to single-chain fusion proteins comprising three soluble TNF superfamily (TNFSF) cytokine domains and nucleic acid molecules encoding these fusion proteins. The fusion proteins are substantially non-aggregating and suitable for therapeutic, diagnostic and/or research applications.

Claim (Index 10):
An isolated host cell or a non-human organism transformed or transfected with the nucleic acid molecule of  claim 9 .

Metadata:
- Claim Count in Document: 23.0
- Percentile: 97.0
- Lexical Diversity: 1.19444
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15172393', '15643787', '13055109', '14558681', '14320261']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8225762508620991
- 35 USC 102 Novelty (BERT): 0.6067198367055808
- Combined Prediction Score: 0.8009906094464472
- Mean Citation Score: 617.6542900000002
- Max Citation Score: 642.7322
- Similarity Product: 462.4616432287692

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test